Sino Biological is engaged in the research and development of recombinant protein and antibody reagents for the treatment of cancer and arthritis.
Business Model:
Revenue: $0
Employees: 201-500
Address: No.18 Kechuang 10th Street
City: Beijing
State: beijing municipality
Zip: 100176
Country: CN
Sino Biological is engaged in the research and development of recombinant protein and antibody reagents for the treatment of cancer and arthritis.
Contact Phone:
Contact Email:
Listed Exchange:
Shenzhen Stock Exchange
IPO Date:
8/16/2021
Ticker Symbol:
301047
IPO Price:
$89.27054535345266/share
Amount Raised:
$769M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2023 | PhaBuilder | Series A | 0 |
11/2022 | PhaBuilder | Series A | 0 |
2/2023 | PhaBuilder | Series A | 0 |
11/2022 | PhaBuilder | Series A | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2021 | IPO | $768.7M | 7/2017 | Series A | $29M |
Qiming Venture Partners |
5/2018 | Venture Round | 1 | $15.8M |
Qiming Venture Partners Qiming Venture Partners |
7/2017 | Series A | 1 | $29.4M |
Qiming Venture Partners Qiming Venture Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|